Аннотация:
Background: Transurethral resection of the prostate (TURP) is considered to be the standard treatment for patients with benign prostatic obstruction (BPO) ≤80 mL. However, up to 14.7[%] of the patients require secondary TURP due to recurrent BPO. The aim of our study was to describe specific features of holmium laser enucleation of the prostate (HoLEP) and thulium laser enucleation of the prostate (ThuLEP) in patients with recurrent BPO after previous prostate surgery. Materials and Methods: A total of 768 consecutive patients from our prospective collected database were retrospectively reviewed and divided into 4 groups: group A (489 patients) and group C (253 patients) underwent primary HoLEP and ThuLEP treatment, while group B (17 patients) and D (9 patients) included patients with recurrent BPO who were treated with HoLEP and ThuLEP, respectively. Results: There were no significant differences in preoperative parameters between the groups at primary (A and C) and secondary (B and D)
Ключевые слова:
Benign prostatic obstruction; Endoscopic laser enucleation; Recurrent adenoma
aged; Article; feasibility study; follow up; human; major clinical study; male; micturition; operation duration; preoperative period; priority journal; prostate hypertrophy; prostate surgery; recurrent disease; retrospective study; scoring system; urogenital system parameters; adverse device effect; devices; drug therapy; factual database; feasibility study; low level laser therapy; middle aged; pathophysiology; prostate hypertrophy; recurrent disease; solid state laser; transurethral resection; treatment outcome; thulium; Aged; Databases, Factual; Feasibility Studies; Humans; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Prostatic Hyperplasia; Recurrence; Retrospective Studies; Thulium; Transurethral Resection of Prostate; Treatment Outcome
Becker B.
Netsch C.
Gly'bochko P. V. Petr Vitalyevich 1964-
Rapoport L. M. Leonid Moiseevich 1956-
Taratkin M. S. Mark Sergeevich 1993-
Enikeev D. V. Dmitrij Viktorovich 1982-
Беcкер Б.
Нецч C.
Глыбочко П. В. Петр Витальевич 1964-
Рапопорт Л. М. Леонид Моисеевич 1956-
Тараткин М. С. Марк Сергеевич 1993-
Еникеев Д. В. Дмитрий Викторович 1982-
A Feasibility Study Utilizing the Thulium and Holmium Laser in Patients for the Treatment of Recurrent Benign Prostatic Hyperplasia after Previous Prostatic Surgery
A Feasibility Study Utilizing the Thulium and Holmium Laser in Patients for the Treatment of Recurrent Benign Prostatic Hyperplasia after Previous...
Текст визуальный непосредственный
Urologia Internationalis
S. Karger AG
Vol.101, Issue2 P. 212-218
2018
Статья
Benign prostatic obstruction Endoscopic laser enucleation Recurrent adenoma
aged Article feasibility study follow up human major clinical study male micturition operation duration preoperative period priority journal prostate hypertrophy prostate surgery recurrent disease retrospective study scoring system urogenital system parameters adverse device effect devices drug therapy factual database feasibility study low level laser therapy middle aged pathophysiology prostate hypertrophy recurrent disease solid state laser transurethral resection treatment outcome thulium Aged Databases, Factual Feasibility Studies Humans Laser Therapy Lasers, Solid-State Male Middle Aged Prostatic Hyperplasia Recurrence Retrospective Studies Thulium Transurethral Resection of Prostate Treatment Outcome
Background: Transurethral resection of the prostate (TURP) is considered to be the standard treatment for patients with benign prostatic obstruction (BPO) ≤80 mL. However, up to 14.7[%] of the patients require secondary TURP due to recurrent BPO. The aim of our study was to describe specific features of holmium laser enucleation of the prostate (HoLEP) and thulium laser enucleation of the prostate (ThuLEP) in patients with recurrent BPO after previous prostate surgery. Materials and Methods: A total of 768 consecutive patients from our prospective collected database were retrospectively reviewed and divided into 4 groups: group A (489 patients) and group C (253 patients) underwent primary HoLEP and ThuLEP treatment, while group B (17 patients) and D (9 patients) included patients with recurrent BPO who were treated with HoLEP and ThuLEP, respectively. Results: There were no significant differences in preoperative parameters between the groups at primary (A and C) and secondary (B and D)